Corporations and investors lean on Capstone’s expertise in healthcare policy to gain valuable insights on regulatory risks and global opportunities. Our process is designed to uncover innovative policy-driven ideas, advising private equity firms, corporations, and investors on the impact of regulation on potential and existing investments.

We leverage our ability to wade through public records of existing and proposed regulation, legislation, and other policy efforts. We combine that with our relationships with major industry associations, as well as senior policymakers and influential experts, to add value and identify opportunities for investment growth.

Capstone has been a trusted adviser on many public transactions. Below is a selection of recent transactions.​

Capstone leverages a proprietary and purpose-built network of experts and other professionals involved in policy formation, influence, and analysis, including current and former policymakers, trade associations, lobbyists, government affairs staff, think tanks, and other policy thought leaders.

Capstone works across both the capital structure and the investment lifecycle. Our diversified client set includes private equity, growth equity, and venture capital firms; private credit and direct lending firms; long-only, long/short, multi-manager, and distressed/opportunistic credit hedge funds; and portfolio companies and corporates.

One dedicated team will work with you from scope writing to final deliverable to avoid misplaced incentives or less actionable products. Our involvement from start to finish ensures that no questions are left unanswered and we can direct resources toward policy/commercial considerations that may be less obvious but more impactful.

Private markets clients who work with Capstone have access to client-only events with industry leaders, policymakers, and Capsone analysts in 2024, Capstone held 41 healthcare policy-focused events exclusively for our clients.